14 Photos and videos
#SEMSS2023 is off and running, with a great keynote from @LiottaLab, heading into breakout sessions and posters this afternoon! Thanks to the @SEmdphd organizing committees for a great start to the weekend!
1
10
944
Liotta Research Group retweeted
3 Oct 2023
.@BayhDole American Innovator Award recipient and @EmoryUniversity professor Dr. @LiottaLab, best known for his groundbreaking discoveries in HIV treatment, was featured in an article by #eGreenews! Read it here ⤵️
buff.ly/3F0y0pV
1
189
Liotta Research Group retweeted
25 Sep 2023
Congrats to #EmoryCFAR Member, Dennis Liotta (@LiottaLab) who was honored at the White House for innovation in #HIV treatment! Dr. Liotta was one of five to receive an inaugural @BayhDole American Innovator Award. Learn more via @EmoryNews: news.emory.edu/stories/2023/…
7
16
994
Liotta Research Group retweeted
21 Aug 2023
As we welcome students back to school for the fall semester, our scholars offer advice to thrive in graduate school ow.ly/oOCc50PAT8K @LiottaLab
4
9
747
Liotta Research Group retweeted
17 Aug 2023
Congrats to Emory's Dennis Liotta for his great work that is highlighted here.
16 Aug 2023
.@BayhDole's new "Faces of American Innovation" report profiles five amazing people who changed the world through the #BayhDole Act:
🧬 Katalin Karikó
💊 Dennis Liotta
💉 Carol Mimura
🔋 Yan Wang
🚘 Peter Stern
Read the full #BayhDoleFOAI report below! ⬇️
buff.ly/3OygdLb
4
7
1,948
11 Jan 2023
Nucleoside- and nucleotide-based therapies including Tenofovir (TFV) are commonly given to patients as prodrugs to maximize bioavailability. We designed three series of novel TFV prodrugs shown to optimize antiviral activity and metabolic stability: frontiersin.org/articles/10.…
23
2,481
7 Dec 2022
A series of NMDA receptor subunit 2B-selective inhibitors show enhanced activity at a more acidic extracellular pH relative to physiologic pH. This property renders compounds more effective at synapses responding to a high frequency of action potentials. jpet.aspetjournals.org/conte…
7
7 Dec 2022
Happy Holidays from our Liotta Family to yours! So much fun at our annual Holiday potluck!
1
22
16 Nov 2022
CXCR4 antagonist TIQ15 was rationally modified to improve drug-like properties. Introducing a nitrogen atom in the tetrahydroisoquinoline ring reduces inhibition of the CYP2D6 enzyme while retaining CXCR4 potency.
pubs.acs.org/doi/pdf/10.1021…
5
5 Nov 2022
Our very own @HGold26 presenting her work at the @WinshipAtEmory Winship Scientific Symposium yesterday! 🧪🧬🧫
2
29
Liotta Research Group retweeted
31 Oct 2022
"Try to be an intellectual sponge." Alumnus Dennis Liotta (@liottalab), whose work transformed HIV treatment, shares his advice for today’s @gc_cuny Ph.D. students gc.cuny.edu/news/alumnus-den… @asrc_gc @GC_ChemistryPhD @GCSciences @emorychem
ALT Dennis Liotta (center) with Graduate Center Ph.D. students. From left: Tamar Mehlman, Biochemistry Ph.D. program; Priyasha Deshpande, Biochemistry Ph.D. program; Naxhije (Gia) Berisha, Chemistry Ph.D. program; Dhawnit Dave, Chemistry Ph.D. program; Jim Xu, Biochemistry Ph.D. program; David Dansu, Biochemistry Ph.D. program; Alfredo Vidal-Ceballos, Biochemistry Ph.D. program; and Sami Sauma, Biology Ph.D. program. (Photo credit: Shanté Booker)
1
8
27
26 Oct 2022
TFV is the cornerstone NtRTI in many combination antiretroviral therapies prescribed to patients living with HIV. This paper describes two novel TFV prodrugs with improved metabolic stability, half-life, and pharmacokinetic traits: pubs.acs.org/doi/10.1021/acs…
8
.@GC_CUNY alumnus @LiottaLab's innovations have resulted in 18 life-saving FDA-approved antiviral therapeutics, including the first-ever combination therapy for HIV/AIDS as a once-daily pill. Tune into his talk on Oct. 28 to learn all about his research! ow.ly/AoTO50LjsxY
6
7
Join us in welcoming @GC_CUNY alumnus and Samuel Candler Dobbs Professor of Chemistry @LiottaLab, on Oct. 28 for a talk about novel therapeutics for treating cancers, neurological disorders and viral diseases. @GCsciences ow.ly/UbWr50LjfJn
3
4
Samuel Candler Dobbs Professor of Chemistry @LiottaLab, recognized as one of the premier discoverers of novel therapeutics in the U.S., is presenting a talk titled “Novel Therapeutics for Treating Cancers, Neurological Disorders & Viral Diseases” on 10/28. ow.ly/yoZJ50LjbxO
3
5
13 Oct 2022
From Liotta group member Dr. Luke Hodson - “I had such a great time showcasing Agrithera’s cannabinoid prodrug technology at the #cghisummit on Tuesday. Special congrats to Dr. Dennis Liotta, for being awarded runner up in the pitch rounds!” Congratulations @EricJMillerLab @gjfCD
1
6
4 Oct 2022
Congratulations Dr. Dentmon on an an exceptional thesis defense delivery today and a well-earned doctorate!
1
1
29
30 Sep 2022
Great work @kristhechemist !
27 Sep 2022
▶️ #Fluorescence Quenching of Xanthene #Dyes during Amide Bond Formation Using DMTMM
👥 Kristen N. Patterson, Misael A. Romero-Reyes, and Jennifer M. Heemstra
go.acs.org/2jc
@jenheemstra @HeemstraLab @WashUChem @EmoryChem
7
Liotta Research Group retweeted
27 Sep 2022
▶️ #Fluorescence Quenching of Xanthene #Dyes during Amide Bond Formation Using DMTMM
👥 Kristen N. Patterson, Misael A. Romero-Reyes, and Jennifer M. Heemstra
go.acs.org/2jc
@jenheemstra @HeemstraLab @WashUChem @EmoryChem
4
9